BackCyanotech Overview

Cyanotech Current Assets

Track Cyanotech's current assets ($11M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$10.94M
↑ 3.97% YoYΔ $418000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Cyanotech Current Assets History

Loading

Cyanotech vs. peers: Current Assets Comparison

Loading

Cyanotech Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Cyanotech (CYAN) FAQ

Cyanotech (CYAN) currently reports a current assets of $11M as of June 2026. That compares with $11M in the prior-year period — up 4.0% year over year. Use the charts on this page to explore Cyanotech's current assets history and peer comparisons.

Cyanotech's current assets increased from $11M to $11M — a 4.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cyanotech reported $11M in current assets as of June 2026. That compares with $11M in the prior-year period — up 4.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $11M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cyanotech, and consider following CYAN for alerts when major investors trade the stock.

Cyanotech is classified in the Healthcare sector. On current assets, it currently shows $11M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CYAN with unrelated industries.